MacroGenics | MGNX - Loan Capital


MacroGenics reported $70M in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
AbbVie USD 62.97B 12M Sep/2025
Amgen USD 50B 2.43B Dec/2025
AstraZeneca USD 26.14B 19.58B Dec/2025
Biogen USD 6.29B 1.4M Sep/2025
Bristol-Myers Squibb USD 42.85B 1.62B Dec/2025
Daiichi Sankyo JPY 300.15B 199.41B Dec/2025
Eli Lilly USD 40.87B 5.6M Dec/2025
Genmab DKK 5.14B 5.01B Dec/2025
Geron USD 119.55M 283K Dec/2025
Gilead Sciences USD 22.14B 5M Sep/2025
J&J USD 39.44B 30M Dec/2025
Karyopharm Therapeutics USD 278.22M 278.22M Dec/2025
MacroGenics USD 70M 256K Dec/2025
Merck USD 39.97B 6B Sep/2025
Pfizer USD 57.41B 93M Sep/2025
Puma Biotechnology USD 10.87M 222K Jun/2025
Regeneron Pharmaceuticals USD 2.71B 720.4M Dec/2025
Roche Holding CHF 27.43B 966M Dec/2025
Xencor USD 76.48M 11.29M Dec/2025